glp-1 incretin is released from the small intestine after meal ingestion and PDB-101: Molecule of the Month:

Payment Security and Methods When purchasing retatrutidewhether for research purposes or as part of an obesity treatment planensuring payment security is a top priority

Applying the patch for longer periods can lead to side effects such as: Erythema (redness) Pruritus (itching) Contact dermatitis Skin inflammation Burning sensation GLP-1 transdermal patches may also cause hypersensitivity reactions and skin sensitization after repeated exposure

This appears to be a variant of Pendulum Glucose Control

Herbal GLP-1 patches might have these potential benefits, but their effectiveness is questionable 19

GLP-1 medications carry FDA warnings about potential risks including pancreatitis, gallbladder disease, and acute kidney injury with dehydration

GLP-1 receptor agonists include semaglutide, dulaglutide, and liraglutide, used for type 2 diabetes and weight management